Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 1108-1117

  Zahm, Adam M ^a   Hand, Nicholas J ^a   Tsoucas, Daphne M ^a   Le Guen, Claire L ^a   Baldassano, Robert N ^a   Friedman, Joshua R ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Circulating microRNA; Crohn's disease; Inflammatory bowel disease; MicroRNA; Serum microRNA; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; MERCAPTOPURINE; METHOTREXATE; MICRORNA; MICRORNA 142 3P; MICRORNA 146A; MICRORNA 192; MICRORNA 194; MICRORNA 200B; MICRORNA 21; MICRORNA 24; MICRORNA 375; MICRORNA LET 7I; STEROID; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CACO 2 CELL LINE; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FOLDING; RECTUM MUCOSA; RNA ANALYSIS; STEROID THERAPY; ULCERATIVE COLITIS; VALIDATION STUDY; BIOPSY; CELL LINE; CHILD; GENETICS; INFLAMMATORY BOWEL DISEASE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; BLOOD ANALYSIS; ENDOSCOPY; ENZYME ACTIVITY; RECTUM BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; BIOPSY; CELL LINE; CHILD; COLONOSCOPY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM;

EID: 84906789813     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.02.012     Document Type: Article

References (47)

1. Baldassano R.N., Piccoli D.A. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol. Clin. North Am. 1999 Jun, 28(2):445-458.
2. Heikenen J.B., Werlin S.L., Brown C.W., Balint J.P. Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflamm Bowel Dis 1999 Aug, 5(3):158-160.
3. Spray C., Debelle G.D., Murphy M.S. Current diagnosis, management and morbidity in paediatric inflammatory bowel disease. Acta Paediatr 2001 Apr, 90(4):400-405.
4. Seidman E., LeLeiko N., Ament M., Berman W., Caplan D., Evans J., et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991 May, 12(4):424-438.
5. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008 Sep 4, 455(7209):58-63.
6. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008 Sep 4, 455(7209):64-71.
7. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010 Aug 12, 466(7308):835-840.
8. Bazzini A.A., Lee M.T., Giraldez A.J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 2012 Apr 13, 336(6078):233-237.
9. Djuranovic S., Nahvi A., Green R. MiRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012 Apr 13, 336(6078):237-240.
10. McKenna L.B., Schug J., Vourekas A., McKenna J.B., Bramswig N.C., Friedman J.R., et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010 Nov, 139(5):654-664. [64 e1].
11. Biton M., Levin A., Slyper M., Alkalay I., Horwitz E., Mor H., et al. Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol 2011 Mar, 12(3):239-246.
12. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008 Nov, 135(5):1624-1635. e24.
13. Wu F., Zhang S., Dassopoulos T., Harris M.L., Bayless T.M., Meltzer S.J., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010 Oct, 16(10):1729-1738.
14. Fasseu M., Treton X., Guichard C., Pedruzzi E., Cazals-Hatem D., Richard C., et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 2010, 5(10).
15. Pekow J.R., Dougherty U., Mustafi R., Zhu H., Kocherginsky M., Rubin D.T., et al. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 2012 Jan, 18(1):94-100.
16. Iborra M., Bernuzzi F., Correale C., Vetrano S., Fiorino G., Beltran B., et al. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 2013 Aug, 173(2):250-258.
17. Yang Y., Ma Y., Shi C., Chen H., Zhang H., Chen N., et al. Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun 2013 May 17, 434(4):746-752.
18. Polito J.M., Childs B., Mellits E.D., Tokayer A.Z., Harris M.L., Bayless T.M. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996 Sep, 111(3):580-586.
19. Levine A., Griffiths A., Markowitz J., Wilson D.C., Turner D., Russell R.K., et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011 Jun, 17(6):1314-1321.
20. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008 Jul 29, 105(30):10513-10518.
21. Andreasen D., Fog J.U., Biggs W., Salomon J., Dahslveen I.K., Baker A., et al. Improved microRNA quantification in total RNA from clinical samples. Methods 2010 Apr, 50(4):S6-S9.
22. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004 Jan 1, 32(Database issue):D109-D111.
23. Haraguchi T., Ozaki Y., Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009 Apr, 37(6):e43.
24. Shin K.J., Wall E.A., Zavzavadjian J.R., Santat L.A., Liu J., Hwang J.I., et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci U S A 2006 Sep 12, 103(37):13759-13764.
25. Xie J., Ameres S.L., Friedline R., Hung J.H., Zhang Y., Xie Q., et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 2012 Apr, 9(4):403-409.
26. Hand N.J., Horner A.M., Master Z.R., Boateng L.A., LeGuen C., Uvaydova M., et al. MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia. J Pediatr Gastroenterol Nutr 2012 Feb, 54(2):186-192.
27. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001 Apr 24, 98(9):5116-5121.
28. Pavlidis P., Noble W.S. Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003 Jan 22, 19(2):295-296.
29. Holm S. A simple sequential rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
30. Girardin S.E., Hugot J.P., Sansonetti P.J. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003 Dec, 24(12):652-658.
31. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhaes J.G., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010 Jan, 11(1):55-62.
32. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 May 31, 411(6837):599-603.
33. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 May 31, 411(6837):603-606.
34. Hampe J., Cuthbert A., Croucher P.J., Mirza M.M., Mascheretti S., Fisher S., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001 Jun 16, 357(9272):1925-1928.
35. Zahm A.M., Thayu M., Hand N.J., Horner A., Leonard M.B., Friedman J.R. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011 Jul, 53(1):26-33.
36. Shi C., Liang Y., Yang J., Xia Y., Chen H., Han H., et al. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. PLoS One 2013, 8(6):e66814.
37. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., et al. MiRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2007, 2(10):e1020.
38. Chen Y., Xiao Y., Ge W., Zhou K., Wen J., Yan W., et al. miR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis 2013, 4:e541.
39. Takagi T., Naito Y., Mizushima K., Hirata I., Yagi N., Tomatsuri N., et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 2010 May, 25(Suppl. 1):S129-S133.
40. Feng X., Wang H., Ye S., Guan J., Tan W., Cheng S., et al. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IkappaBalpha. PLoS One 2012, 7(12):e52782.
41. Lin J., Welker N.C., Zhao Z., Li Y., Zhang J., Reuss S.A., et al. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Mod Pathol 2013 Sep 20, (Epub ahead of print). 10.1038/modpathol.2013.152.
42. Koukos G., Polytarchou C., Kaplan J.L., Morley-Fletcher A., Gras-Miralles B., Kokkotou E., et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 2013 Oct, 145(4):842-852. e2.
43. Wendlandt E.B., Graff J.W., Gioannini T.L., McCaffrey A.P., Wilson M.E. The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-kappaB activation. Innate Immunol 2012 Dec, 18(6):846-855.
44. Bian Z., Li L., Cui J., Zhang H., Liu Y., Zhang C.Y., et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011 Dec, 225(4):544-553.
45. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005 Feb 4, 307(5710):731-734.
46. Paraskevi A., Theodoropoulos G., Papaconstantinou I., Mantzaris G., Nikiteas N., Gazouli M. Circulating microRNA in inflammatory bowel disease. J. Crohn's Colitis 2012 Oct, 6(9):900-904.
47. Tukey J.W. Exploratory data analysis 1977, Addison-Wesley, Reading, MA.